
Intense pulsed light (IPL) therapy has become one of the most advanced and effective treatments for chronic dry eye. At Kapperman McGarvey Eye Group, we offer Lumenis OptiLight IPL to address the root causes of dry eye disease.
Dry eye disease is often caused by meibomian gland dysfunction (MGD), a condition in which the oil glands along the eyelids become blocked or inflamed. These glands are responsible for producing the oily layer of your tears that prevents rapid evaporation. When they are not functioning properly, tears evaporate too quickly, leaving the eyes irritated and inflamed.
Common symptoms of dry eye include:
While artificial tears may offer temporary relief, they do not treat the underlying inflammation that often drives the condition.
Lumenis OptiLight IPL is the first and only FDA-approved IPL treatment specifically designed for managing dry eye disease caused by meibomian gland dysfunction. This advanced technology uses precisely controlled pulses of light applied to the skin around the eyes.
The light energy reduces inflammation, targets abnormal blood vessels that contribute to redness, and helps improve the function of the meibomian glands. As gland function improves, tear quality becomes more stable, leading to longer-lasting moisture and improved comfort.
OptiLight works by addressing several underlying factors that contribute to dry eye:
Most patients undergo a series of treatments spaced a few weeks apart for optimal results.
OptiLight IPL treatments are quick and comfortable. Protective shields are placed over the eyes, and a gel is applied to the treatment area. Pulses of light are delivered to the skin below the eyes and along the cheeks.
The procedure typically takes about 15-30 minutes. There is minimal downtime, and patients can usually return to normal activities the same day. Some may experience mild redness that resolves quickly.
Patients choose OptiLight because it offers:
Many patients notice a significant reduction in dryness, irritation, and reliance on artificial tears after completing their treatment series.
Dry eye disease can affect everything from reading and driving to working comfortably on a computer. Lumenis OptiLight IPL offers a breakthrough approach by treating the underlying causes of inflammation and gland dysfunction rather than simply masking symptoms. At Kapperman McGarvey Eye Group, we offer advanced, evidence-based solutions that restore comfort, protect eye health, and improve quality of life.
If you are ready to experience lasting relief from dry eye symptoms, schedule a consultation with Kapperman McGarvey Eye Group to learn if OptiLight IPL is right for you. Visit our website at kmeyegroup.com or call (423) 892-2020 to book an appointment today.